Arkolith/Insider Trading/RPRX/Form 4

Coyne Terrance P.

EVP & CFORoyalty Pharma plc (RPRX) · full profile →Form 4 · filed Nov 26, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.7M
Net Open-Market Flow
-$2.7M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 24, 2025Sell(S)55K$38.67$2.1M669K
Nov 24, 2025Sell(S)624$37.96$24K51K
Nov 24, 2025Sell(S)3K$38.67$121K52K
Nov 24, 2025Sell(S)11K$37.96$406K658K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001814876-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML